1-5 of 5
Maria Luisa Bonanomi
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Increased tumor burden in patients with chronic myeloid leukemia after 36 months of imatinib discontinuation

Clinical Trials & Observations
Elisa Diral, Silvia Mori, Laura Antolini, Elisabetta Abruzzese, Philipp Le Coutre, Bruno Martino, Ester Pungolino, Chiara Elena, Micaela Bergamaschi, Sarit Assouline, Eros Di Bona, Antonella Gozzini, Marcio Andrade-Campos, Fabio Stagno, Alessandra Iurlo, Alessandra Pirola, Diletta Fontana, Jessica Petiti, Maria Luisa Bonanomi, Patrizia Crivori, Rocco Piazza, Carmen Fava, Carlo Gambacorti-Passerini
Journal: Blood
Blood (2020) 136 (19): 2237–2240.
https://doi.org/10.1182/blood.2019004371
Published: 2020
Includes: Supplemental data
Journal Articles

Increased Tumour Burden over a 36 Month Period in Chronic Myeloid Leukemia Patients Following Imatinib Discontinuation: Role of Digital PCR

Elisa Diral, MD, Philipp Le Coutre, MD, Enrico Marco Gottardi, Chiara Elena, MD, Micaela Bergamaschi, MD, Sarit Assouline, MD, Eros Di Bona, MD, Jessica Petiti, PhD, Fabio Stagno, MD, Alessandra Iurlo, MD PhD, Dong-Wook Kim, Alessandra Pirola, MSc, Maria Luisa Bonanomi, Patrizia Crivori, PhD, Rocco Piazza, MD PhD, Carmen Fava, Carlo Gambacorti-Passerini, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 29.
https://doi.org/10.1182/blood-2019-125226
Published: 2019
Journal Articles

Imatinib Suspension and Validation (ISAV) Study: Final Results at 79 Months

Silvia Mori, PhD, Philipp le Coutre, MD, Elisabetta Abruzzese, Bruno Martino, MD, Ester Pungolino, Chiara Elena, MD, Micaela Bergamaschi, MD, Sarit Assouline, Eros Di Bona, MD, Antonella Gozzini, MD, Marcio Andrade, MD, Fabio Stagno, Alessandra Iurlo, Dong-Wook Kim, MD PhD, Michela Luciani, RN, PhD, Alessandra Pirola, M.Sc., Maria Luisa Bonanomi, Patrizia Crivori, PhD, Rocco Piazza, MD PhD, Carlo Gambacorti-Passerini, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 461.
https://doi.org/10.1182/blood-2018-99-112982
Published: 2018
Journal Articles

Imatinib Suspension and Validation Study: Results from the Isav Study at 62 Months

Silvia Mori, PhD, Philipp D. le Coutre, MD, Elisabetta Abruzzese, MD, Bruno Martino, Ester Pungolino, Chiara Elena, Micaela Bergamaschi, MD, Sarit Assouline, MD, Eros Di Bona, MD, Antonella Gozzini, MD, Marcio Andrade, Fabio Stagno, MD PhD, Alessandra Iurlo, MD PhD, Michela Luciani, Eleonora Parisse, Dong-Wook Kim, MD PhD, Alessandra Pirola, M.Sc., Michela Viltadi, Maria Luisa Bonanomi, Patrizia Crivori, Rocco Piazza, MD PhD, Carlo Gambacorti-Passerini, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 2870.
https://doi.org/10.1182/blood.V130.Suppl_1.2870.2870
Published: 2017
Journal Articles

Imatinib Suspension and Validation (ISAV) Study: Results at 24 Months

Silvia Mori, PhD, Philipp le Coutre, MD, Elisabetta Abruzzese, MD, Bruno Martino, MD, Ester Pungolino, MD, Chiara Elena, MD, Ivana Pierri, MD, Sarit E. Assouline, MDMSc, Anna D'Emilio, MD, Antonella Gozzini, MD, Pilar Giraldo, MD PhD, Fabio Stagno, MD PhD, Alessandra Iurlo, MD PhD, Andrea Aroldi, MD, Michela Luciani, RN, Giulia De Riso, RN, Kim Dong-Wook, MD PhD, Alessandra Pirola, MSc, Anna Petroccione, Maria Luisa Bonanomi, Patrizia Crivori, PhD, Rocco Piazza, MDPhD, Carlo Gambacorti-Passerini, MD
Journal: Blood
Blood (2015) 126 (23): 2775.
https://doi.org/10.1182/blood.V126.23.2775.2775
Published: 2015